167 related articles for article (PubMed ID: 15857146)
21. QSAR analysis of some 5-amino-2-mercapto-1,3,4-thiadiazole based inhibitors of matrix metalloproteinases and bacterial collagenase.
Jamloki A; Karthikeyan C; Hari Narayana Moorthy NS; Trivedi P
Bioorg Med Chem Lett; 2006 Jul; 16(14):3847-54. PubMed ID: 16682189
[TBL] [Abstract][Full Text] [Related]
22. A new role for old ligands: discerning chelators for zinc metalloproteinases.
Jacobsen FE; Lewis JA; Cohen SM
J Am Chem Soc; 2006 Mar; 128(10):3156-7. PubMed ID: 16522091
[TBL] [Abstract][Full Text] [Related]
23. Molecular imaging of matrix metalloproteinases in vivo using small molecule inhibitors for SPECT and PET.
Wagner S; Breyholz HJ; Faust A; Höltke C; Levkau B; Schober O; Schäfers M; Kopka K
Curr Med Chem; 2006; 13(23):2819-38. PubMed ID: 17073631
[TBL] [Abstract][Full Text] [Related]
24. Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs).
Rangasamy L; Geronimo BD; Ortín I; Coderch C; Zapico JM; Ramos A; de Pascual-Teresa B
Molecules; 2019 Aug; 24(16):. PubMed ID: 31426440
[TBL] [Abstract][Full Text] [Related]
25. Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs.
Cuniasse P; Devel L; Makaritis A; Beau F; Georgiadis D; Matziari M; Yiotakis A; Dive V
Biochimie; 2005; 87(3-4):393-402. PubMed ID: 15781327
[TBL] [Abstract][Full Text] [Related]
26. N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8.
Campestre C; Agamennone M; Tortorella P; Preziuso S; Biasone A; Gavuzzo E; Pochetti G; Mazza F; Hiller O; Tschesche H; Consalvi V; Gallina C
Bioorg Med Chem Lett; 2006 Jan; 16(1):20-4. PubMed ID: 16242329
[TBL] [Abstract][Full Text] [Related]
27. Discovery of potent, achiral matrix metalloproteinase inhibitors.
Pikul S; McDow Dunham KL; Almstead NG; De B; Natchus MG; Anastasio MV; McPhail SJ; Snider CE; Taiwo YO; Rydel T; Dunaway CM; Gu F; Mieling GE
J Med Chem; 1998 Sep; 41(19):3568-71. PubMed ID: 9733482
[No Abstract] [Full Text] [Related]
28. Structural basis for the highly selective inhibition of MMP-13.
Engel CK; Pirard B; Schimanski S; Kirsch R; Habermann J; Klingler O; Schlotte V; Weithmann KU; Wendt KU
Chem Biol; 2005 Feb; 12(2):181-9. PubMed ID: 15734645
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.
Zhang YM; Fan X; Xiang B; Chakravarty D; Scannevin R; Burke S; Karnachi P; Rhodes K; Jackson P
Bioorg Med Chem Lett; 2006 Jun; 16(12):3096-100. PubMed ID: 16632358
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and molecular modeling study of iminodiacetyl monohydroxamic acid derivatives as MMP inhibitors.
Santos MA; Marques SM; Tuccinardi T; Carelli P; Panelli L; Rossello A
Bioorg Med Chem; 2006 Nov; 14(22):7539-50. PubMed ID: 16875829
[TBL] [Abstract][Full Text] [Related]
31. Assessing the bioisosterism of the trifluoromethyl group with a protease probe.
Jagodzinska M; Huguenot F; Candiani G; Zanda M
ChemMedChem; 2009 Jan; 4(1):49-51. PubMed ID: 19065645
[No Abstract] [Full Text] [Related]
32. Synthesis of chiral 2-(4-phenoxyphenylsulfonylmethyl)thiiranes as selective gelatinase inhibitors.
Lee M; Bernardo MM; Meroueh SO; Brown S; Fridman R; Mobashery S
Org Lett; 2005 Sep; 7(20):4463-5. PubMed ID: 16178559
[TBL] [Abstract][Full Text] [Related]
33. The nonpeptidyl caspase binding radioligand (S)-1-(4-(2-[18F]Fluoroethoxy)-benzyl)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin ([18F]CbR) as potential positron emission tomography-compatible apoptosis imaging agent.
Faust A; Wagner S; Law MP; Hermann S; Schnöckel U; Keul P; Schober O; Schäfers M; Levkau B; Kopka K
Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):67-73. PubMed ID: 17372575
[TBL] [Abstract][Full Text] [Related]
34. 3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.
Li W; Hu Y; Li J; Thomason JR; DeVincentis D; Du X; Wu J; Hotchandani R; Rush TS; Skotnicki JS; Tam S; Chockalingam PS; Morris EA; Levin JI
Bioorg Med Chem Lett; 2009 Aug; 19(16):4546-50. PubMed ID: 19625186
[TBL] [Abstract][Full Text] [Related]
35. Imaging of MMP activity in postischemic cardiac remodeling using radiolabeled MMP-2/9 activatable peptide probes.
van Duijnhoven SM; Robillard MS; Hermann S; Kuhlmann MT; Schäfers M; Nicolay K; Grüll H
Mol Pharm; 2014 May; 11(5):1415-23. PubMed ID: 24641497
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.
Nicolotti O; Catto M; Giangreco I; Barletta M; Leonetti F; Stefanachi A; Pisani L; Cellamare S; Tortorella P; Loiodice F; Carotti A
Eur J Med Chem; 2012 Dec; 58():368-76. PubMed ID: 23149299
[TBL] [Abstract][Full Text] [Related]
37. Identification of highly selective inhibitors of collagenase-1 from combinatorial libraries of diketopiperazines.
Szardenings AK; Antonenko V; Campbell DA; DeFrancisco N; Ida S; Shi L; Sharkov N; Tien D; Wang Y; Navre M
J Med Chem; 1999 Apr; 42(8):1348-57. PubMed ID: 10212120
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and evaluation of new tripeptide phosphonate inhibitors of MMP-8 and MMP-2.
Agamennone M; Campestre C; Preziuso S; Consalvi V; Crucianelli M; Mazza F; Politi V; Ragno R; Tortorella P; Gallina C
Eur J Med Chem; 2005 Mar; 40(3):271-9. PubMed ID: 15725496
[TBL] [Abstract][Full Text] [Related]
39. Natural products as a gold mine for selective matrix metalloproteinases inhibitors.
Wang L; Li X; Zhang S; Lu W; Liao S; Liu X; Shan L; Shen X; Jiang H; Zhang W; Huang J; Li H
Bioorg Med Chem; 2012 Jul; 20(13):4164-71. PubMed ID: 22658537
[TBL] [Abstract][Full Text] [Related]
40. Peptides, multimers and polymers.
Dijkraaf I; Wester HJ
Handb Exp Pharmacol; 2008; (185 Pt 2):61-92. PubMed ID: 18626599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
